Stem Cell Research (Oct 2021)

Generation and characterization of an endogenously tagged SPG11-human iPSC line by CRISPR/Cas9 mediated knock-in

  • Laura Krumm,
  • Tatyana Pozner,
  • Johanna Kaindl,
  • Martin Regensburger,
  • Claudia Günther,
  • Soeren Turan,
  • Reza Asadollahi,
  • Anita Rauch,
  • Beate Winner

Journal volume & issue
Vol. 56
p. 102520

Abstract

Read online

Pathogenic bi-allelic variants in the SPG11 gene result in rare motor neuron disorders such as Hereditary Spastic Paraplegia type 11, Charcot-Marie Tooth, and Juvenile Amyotrophic Lateral Sclerosis-5. The main challenge in SPG11-linked disease research is the lack of antibodies against SPG11 encoded spatacsin. Here, we describe the CRISPR/Cas9 mediated generation and validation of an endogenously tagged SPG11- human iPSC line that contains an HA tag at the C-terminus of SPG11. The line exhibits multi-lineage differentiation potential and holds promise for studying the role of spatacsin and for the elucidation of SPG11-associated pathogenesis.Resource Table: